The characterization and validation of regulated cell death-related genes in chronic rhinosinusitis with nasal polyps

Hong-Xia Li1, Jing Fei2, Wei Xu2

  • 1Department of Otolaryngology-Head and Neck Surgery, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China; Metabolic Vascular Diseases Key Laboratory of Sichuan Province, and Metabolic Vascular Diseases Key Laboratory of Sichuan-Chongqing Cooperation, Luzhou, Sichuan 646000, China.

PubMed
Abstract

Insights

This study reveals 8 regulated cell death (RCD) subtypes are active in chronic rhinosinusitis with nasal polyps (CRSwNP), with a new index showing diagnostic potential for this complex airway disease.

Area of Science:

  • Molecular Biology
  • Immunology
  • Pathophysiology

Background:

  • Regulated cell death (RCD) pathways are crucial in various diseases, but their role in chronic rhinosinusitis with nasal polyps (CRSwNP) is not well understood.
  • Investigating RCD mechanisms is essential for understanding CRSwNP pathogenesis and progression.

Purpose of the Study:

  • To systematically investigate the involvement and functional implications of diverse RCD subtypes in CRSwNP.
  • To identify key RCD-related genes and develop a diagnostic index for CRSwNP.

Main Methods:

  • Utilized transcriptomic datasets from Gene Expression Omnibus (GEO) and compiled RCD gene sets.
  • Employed Gene Set Variation Analysis (GSVA), Weighted Gene Co-expression Network Analysis (WGCNA), and LASSO regression to identify RCD patterns and hub genes.
  • Conducted single-cell RNA sequencing (scRNA-seq) for cell-type specific analysis and clinical validation using qRT-PCR and VAS scores.

Main Results:

  • Identified significant upregulation of 8 RCD subtypes in CRSwNP, including apoptosis, ferroptosis, and necroptosis.
  • Discovered RCD-related genes are involved in epithelial-mesenchymal transition (EMT) and immune-inflammatory regulation.
  • Developed a novel cell death index (CDI) using 8 key genes (PTHLH, GRINA, S100A9, SCG2, HMOX1, RNF183, TYROBP, SEMA7A) that demonstrated high diagnostic performance and correlated with disease severity and immune cell infiltration.

Conclusions:

  • Established an RCD activation signature in CRSwNP, highlighting 8 key cell death modalities and their regulatory genes.
  • The novel CDI shows promise as a diagnostic tool for CRSwNP.
  • RCD pathways likely contribute to CRSwNP progression via EMT and amplified inflammation, offering potential therapeutic targets.

Related Concept Videos